Danitracen

Tetracyclic antidepressant From Wikipedia, the free encyclopedia

Danitracen (WA 335) is an antidepressant compound developed in the 1970s. Danitracen acts by blocking central and peripheral 5-HT receptors: it potentiates testosterone-induced sexual behavior in rats and abolishes the 5-hydroxytryptophan (5-HTP) induced hypermotility in mice. In amphetamine-treated rats, administration of danitracen lowered whole brain serotonin and norepinephrine levels. Danitracen was investigated in clinical trials in depressed patients. At 3 mg/day, danitracen was equipotent to 150 mg/day amitriptyline.[1][2][3][4][5][6]

CAS Number
Quick facts Identifiers, CAS Number ...
Danitracen
Identifiers
  • 4-(6H-benzo[c][1]benzothiepin-11-ylidene)-1-methylpiperidine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H21NO
Molar mass291.394 g·mol−1
3D model (JSmol)
  • CN1CCC(=C2C3=CC=CC=C3C(C4=CC=CC=C42)O)CC1
  • InChI=1S/C20H21NO/c1-21-12-10-14(11-13-21)19-15-6-2-4-8-17(15)20(22)18-9-5-3-7-16(18)19/h2-9,20,22H,10-13H2,1H3
  • Key:HLBRHTFSMMEHPK-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI